Time Restricted Eating During Chemotherapy for Breast Cancer

Time Restricted Eating During Chemotherapy for Breast Cancer

Recruiting N/A Interventional Study
Breast Cancer Female
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
25 – 99
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
University of Illinois at Chicago · Other
Who this trial is looking for

This trial is looking for women with early-stage breast cancer to explore if time-restricted eating can improve their treatment results. Participants will follow a specific eating schedule alongside a Mediterranean diet during chemotherapy.

Are You a Good Fit for This Trial?
Rules you out Metastatic breast cancerType 1 diabetesType 2 diabetesEating disorders

You may be able to join if

  • I am between 25 and 99 years old.
  • I have been diagnosed with Stage I-III breast cancer.
  • I have good organ function.
  • I can give written consent for this study.
  • I am not pregnant or breastfeeding.
  • I can follow study procedures for the entire trial.

You may not be able to join if

  • I have metastatic breast cancer.
  • I have type 1 or type 2 diabetes.
  • I have a BMI of 40 or higher or below 25.
  • I work the night shift.
  • I have a history of eating disorders.
  • I have gained or lost more than 4 kg in the last 3 months.
  • I have an active infection that needs treatment.
  • I have uncontrolled HIV/AIDS or active hepatitis.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Breast cancer is the most common cancer in the United States however, little is known about how diet can affect cancer treatment. Pre-clinical murine studies report intermittent fasting increases effectiveness of chemotherapy and decreases treatment related adverse events. The proposed research will demonstrate that time restricted eating, a form of intermittent fasting, will improve treatment rel…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 25-99 at time of consent * ECOG 0 or 1 * Breast cancer to meet histologically confirmed Stage I-III. * Demonstrates adequate organ function (absolutely neutrophil count ≥ 1,500/μL). * All screening labs to be obtained within 30 days prior to registration. * Able to provide…
Contacts

Kelsey Gabel, PhD

312-413-8911

kdipma2@uic.edu

CONTACT